Published in J Am Coll Cardiol on March 15, 1999
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy. Eur Heart J (2012) 1.64
The diagnosis and treatment of hypertrophic cardiomyopathy. Dtsch Arztebl Int (2011) 0.84
Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography. Clin Res Cardiol (2010) 0.81
Mechanisms and efficacy of LV pre-excitation for patients with heart failure and supra-normal systolic function. Heart Fail Rev (2000) 0.75
Alcohol septal ablation: in which patients and why? Ann Cardiothorac Surg (2017) 0.75
Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol (2000) 7.39
Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science (1998) 5.98
An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis) N Engl J Med (1998) 4.92
Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med (1998) 4.29
The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 4.15
Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med (2000) 3.99
Profile of preparticipation cardiovascular screening for high school athletes. JAMA (1998) 3.36
The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med (1991) 3.17
Sudden death in young athletes. Circulation (1980) 3.05
Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.97
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol (1995) 2.62
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27
Prognosis of surgically corrected coarctation of the aorta. A 20-year postoperative appraisal. Circulation (1973) 2.21
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA (2000) 2.10
Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med (1999) 2.05
Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation (2000) 2.03
Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med (1986) 2.00
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation (2001) 2.00
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol (1981) 1.89
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1979) 1.80
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
"Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol (1978) 1.76
Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol (1986) 1.70
Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol (1984) 1.67
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation (1981) 1.66
Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.65
Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation (1982) 1.64
Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol (1979) 1.63
Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol (1986) 1.59
Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol (1975) 1.59
A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res (1998) 1.59
Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol (1987) 1.57
Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56
Human heart and platelet actins are products of different genes. Science (1976) 1.55
Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol (1979) 1.55
Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol (1994) 1.52
Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol (2001) 1.44
Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol (1980) 1.42
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation (1979) 1.41
Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation (1977) 1.41
Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation (1991) 1.39
Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation (1999) 1.39
Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation (1991) 1.39
Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol (1995) 1.38
Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation (1999) 1.35
Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation (1978) 1.33
Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.32
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med (1988) 1.31
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation (1981) 1.30
Unusual evolution of acquired infundibular stenosis in patients with ventricular septal defect. Clinical and morphologic observations. Circulation (1973) 1.30
Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation (1992) 1.28
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation (1979) 1.26
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation (1979) 1.25
Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol (1995) 1.23
Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol (1983) 1.22
Potential role of QT interval prolongation in sudden infant death syndrome. Circulation (1976) 1.19
Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function. Br Heart J (1988) 1.16
Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathy. Br Heart J (1992) 1.15
Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.15
Asymmetric septal hypertrophy (ASH) in infancy. Circulation (1974) 1.15
Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J (1982) 1.14
Cardiovascular involvement in osteogenesis imperfecta. Circulation (1986) 1.14
Identification of congenital malformations of the great arteries in infants by real-time two-dimensional echocardiography. Circulation (1975) 1.14
Myocardial ultrastructure in patients with chronic aortic valve disease. Am J Cardiol (1975) 1.13
Doppler echocardiography for assessing left ventricular diastolic function. Ann Intern Med (1988) 1.13
Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance. Am Heart J (1981) 1.13
Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings. Circulation (1977) 1.12
Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1978) 1.12
Ultrastructural features of hypertrophied human ventricular myocardium. Prog Cardiovasc Dis (1979) 1.12
Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation (1995) 1.11
Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs. Am J Cardiol (1993) 1.11
Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol (2001) 1.11
Tunnel subaortic stenosis: left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation (1976) 1.10
Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation (1987) 1.09
Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol (1983) 1.07
Sudden death and the competitive athlete: perspectives on preparticipation screening studies. J Am Coll Cardiol (1986) 1.07
Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography. J Am Coll Cardiol (1992) 1.06
Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation (1985) 1.06
Myocardial disorganisation in hypertrophic cardiomyopathy. Another point of view. Br Heart J (1983) 1.06
Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol (1999) 1.06
Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome. Anatomic basis of mitral regurgitation and peripheral embolization. Circulation (1983) 1.05
Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace (2002) 1.05
Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation (1984) 1.04
Arousal and nonarousal enuretic events. Am J Psychiatry (1969) 1.04
Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol (1989) 1.04